StockData
UNITED THERAPEUTICS Corp logo

UNITED THERAPEUTICS Corp (UTHR) stock

UTHRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3022% above fair value
$577.34−6.76 (-1.16%)

Close on Nov 18, 2026Market cap $24.76BP/E 20.7Yield –

United Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

United Therapeutics's market cap was $25.42B on Nov 11, 2026, against $20.85B a year earlier. Over the last 5 years it ranged from $7.50B to $25.88B, with a median of $12.75B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$25.42B+21.6%
2025Dec 31, 2025$20.90B+32.8%
2024Dec 31, 2024$15.74B+52.4%
2023Dec 29, 2023$10.33B-18.5%
2022Dec 30, 2022$12.67B+30.2%
2021Dec 31, 2021$9.73B+44.2%
2020Dec 31, 2020$6.75B+74.5%
2019Dec 31, 2019$3.87B-18.6%
2018Dec 31, 2018$4.75B-25.7%
2017Dec 29, 2017$6.39B+4.5%
2016Dec 30, 2016$6.12B-14.3%
2015Dec 31, 2015$7.14B+16.2%
2014Dec 31, 2014$6.14B+8.3%
2013Dec 31, 2013$5.67B+107.6%
2012Dec 31, 2012$2.73B-0.8%
2011Dec 30, 2011$2.76B-23.2%
2010Dec 31, 2010$3.59B+48.9%
2009Dec 31, 2009$2.41B–

More United Therapeutics figures

See a number that looks wrong?